VIATRIS INC. Share-based Payment Arrangement, Expense, Tax Benefit
VIATRIS INC. (VTRS) reported Share-based Payment Arrangement, Expense, Tax Benefit of $200.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2023-11-08
- VIATRIS INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2022-09-30 was $200.00K.
- VIATRIS INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2022-06-30 was $500.00K.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month |
|---|---|---|
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-08 | $700.00K derived: sum of 2 quarters · filed 2023-11-08 |
| 2022-06-30 | $500.00K 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |